LRP5 抗体
(Low Density Lipoprotein Receptor-Related Protein 5 (LRP5))
This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. [provided by RefSeq, Nov 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| LRP5 抗体 (AA 1000-1250) | 人 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| LRP5 抗体 (Internal Region) | 人 | 山羊 Polyclonal |
|
|
|
| LRP5 抗体 (AA 451-550) | 人 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 (C-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 (AA 769-1016) | 人 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 (AA 41-130) | 人 | 小鼠 Monoclonal |
|
|
|
| LRP5 抗体 (AA 501-600) | 人 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 (AA 102-336) | 大鼠 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 (AA 41-130) | 人 | 小鼠 Polyclonal |
|
|
|
| LRP5 抗体 (AA 1538-1567) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| LRP5 抗体 (AA 451-550) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 (AA 451-550) (Cy5.5) | 人 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 (AA 451-550) (AbBy Fluor® 647) | 人 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 (AA 451-550) (AbBy Fluor® 680) | 人 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 (AA 451-550) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 (AA 451-550) (Cy5) | 人 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 (AA 451-550) (AbBy Fluor® 750) | 人 | 兔 Polyclonal |
|
|
|
| LRP5 抗体 (AA 451-550) (Biotin) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
1 reference - 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1000-1250
Primary Antibody
- ELISA (ELISA: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2B11
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 质量等级
- Verified
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Internal Region
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 451-550
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB1835
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 1538-1567, C-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 769-1016
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1E9
- 标记
- unconjugated
- 抗体亚型
- IgG1 kappa
- 抗原表位
- AA 41-130
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 501-600
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 102-336
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 41-130
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 1538-1567
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 451-550
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5.5
- 抗体亚型
- IgG
- 抗原表位
- AA 451-550
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 647
- 抗体亚型
- IgG
- 抗原表位
- AA 451-550
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 680
- 抗体亚型
- IgG
- 抗原表位
- AA 451-550
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 451-550
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5
- 抗体亚型
- IgG
- 抗原表位
- AA 451-550
Primary Antibody
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 750
- 抗体亚型
- IgG
- 抗原表位
- AA 451-550
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 451-550
Latest Publications for our LRP5 抗体
: "DDB2 Is a Novel Regulator of Wnt Signaling in Colon Cancer." in: Cancer research, Vol. 77, Issue 23, pp. 6562-6575, (2018) (PubMed).
: "MicroRNA-23a-3p inhibitor decreases osteonecrosis incidence in a rat model." in: Molecular medicine reports, Vol. 16, Issue 6, pp. 9331-9336, (2018) (PubMed).
: "Wnt5a mediated canonical Wnt signaling pathway activation in orthodontic tooth movement: possible role in the tension force-induced bone formation." in: Journal of molecular histology, Vol. 47, Issue 5, pp. 455-66, (2017) (PubMed).
: "Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot." in: PLoS ONE, Vol. 11, Issue 1, pp. e0146710, (2016) (PubMed).
: "Astragaloside IV inhibits the up-regulation of Wnt/?-catenin signaling in rats with unilateral ureteral obstruction." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 33, Issue 5, pp. 1316-28, (2014) (PubMed).
: "Hypoxia-mediated impairment of the mitochondrial respiratory chain inhibits the bactericidal activity of macrophages." in: Infection and immunity, Vol. 80, Issue 4, pp. 1455-66, (2012) (PubMed).
: "Differentiation generates paracrine cell pairs that maintain basaloid mouse mammary tumors: proof of concept." in: PLoS ONE, Vol. 6, Issue 4, pp. e19310, (2011) (PubMed).
: "Coordinated action of CK1 isoforms in canonical Wnt signaling." in: Molecular and cellular biology, Vol. 31, Issue 14, pp. 2877-88, (2011) (PubMed).
: "A p120-catenin-CK1epsilon complex regulates Wnt signaling." in: Journal of cell science, Vol. 123, Issue Pt 15, pp. 2621-31, (2010) (PubMed).
: "Low-density lipoprotein receptor-related protein 5 (LRP5) variation in fracture prone children." in: Bone, Vol. 46, Issue 4, pp. 940-5, (2010) (PubMed).
: "MicroRNA-23a-3p inhibitor decreases osteonecrosis incidence in a rat model." in: Molecular medicine reports, Vol. 16, Issue 6, pp. 9331-9336, (2018) (PubMed).
: "Wnt5a mediated canonical Wnt signaling pathway activation in orthodontic tooth movement: possible role in the tension force-induced bone formation." in: Journal of molecular histology, Vol. 47, Issue 5, pp. 455-66, (2017) (PubMed).
: "Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot." in: PLoS ONE, Vol. 11, Issue 1, pp. e0146710, (2016) (PubMed).
: "Astragaloside IV inhibits the up-regulation of Wnt/?-catenin signaling in rats with unilateral ureteral obstruction." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 33, Issue 5, pp. 1316-28, (2014) (PubMed).
: "Hypoxia-mediated impairment of the mitochondrial respiratory chain inhibits the bactericidal activity of macrophages." in: Infection and immunity, Vol. 80, Issue 4, pp. 1455-66, (2012) (PubMed).
: "Differentiation generates paracrine cell pairs that maintain basaloid mouse mammary tumors: proof of concept." in: PLoS ONE, Vol. 6, Issue 4, pp. e19310, (2011) (PubMed).
: "Coordinated action of CK1 isoforms in canonical Wnt signaling." in: Molecular and cellular biology, Vol. 31, Issue 14, pp. 2877-88, (2011) (PubMed).
: "A p120-catenin-CK1epsilon complex regulates Wnt signaling." in: Journal of cell science, Vol. 123, Issue Pt 15, pp. 2621-31, (2010) (PubMed).
: "Low-density lipoprotein receptor-related protein 5 (LRP5) variation in fracture prone children." in: Bone, Vol. 46, Issue 4, pp. 940-5, (2010) (PubMed).
Aliases for LRP5 抗体
low-density lipoprotein receptor-related protein 5 (LOC100147353) 抗体LDL receptor related protein 5 (LRP5) 抗体
LDL receptor related protein 5 L homeolog (lrp5.L) 抗体
low density lipoprotein receptor-related protein 5 (lrp5) 抗体
LDL receptor related protein 5 (lrp5) 抗体
low density lipoprotein receptor-related protein 5 (Lrp5) 抗体
LDL receptor related protein 5 (Lrp5) 抗体
LDL receptor related protein 5 like (LRP5L) 抗体
bmnd1 抗体
BMND1 抗体
evr1 抗体
EVR1 抗体
evr4 抗体
EVR4 抗体
hbm 抗体
HBM 抗体
lr3 抗体
LR3 抗体
LRP5 抗体
lrp5-A 抗体
LRP6 抗体
lrp7 抗体
LRP7 抗体
mKIAA4142 抗体
oppg 抗体
OPPG 抗体
ops 抗体
OPS 抗体
opta1 抗体
OPTA1 抗体
vbch2 抗体
VBCH2 抗体
Xlrp5 抗体
您还需要查找其他产品吗？
You are here:
